Breaking News, Collaborations & Alliances

Adragos Pharma Acquires Clinigen’s Development Unit, Lamda Laboratories

Significantly expands Adragos' pharmaceutical product development, regulatory affairs and supply chain management services.

Adragos Pharma GmbHa, a contract development and manufacturing organization (CDMO), signed a definitive agreement with global pharmaceutical services company Clinigen Ltd., to acquire Lamda Laboratories S.A. in Athens. In a statement the company said that the acquisition of Lamda Laboratories significantly expands Adragos’ pharmaceutical product development, regulatory affairs and supply chain management services for its global pharmaceutical customers. The Athens site is fully equip...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters